This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma S.a.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: The Innovations of Jean-François Dedieu
Introduction
Jean-François Dedieu is a notable inventor based in Paris, France. He has made significant contributions to the field of gene therapy, particularly in the treatment of restenosis. His innovative approach has garnered attention in the medical community.
Latest Patents
Dedieu holds a patent for a method of treating restenosis through gene therapy. This patent, titled "Gene therapy for restenosis using an adenoviral vector," involves delivering a recombinant suicide-gene-containing adenovirus. This method represents a promising advancement in the treatment of vascular conditions.
Career Highlights
Jean-François Dedieu is associated with Aventis Pharma S.A., a leading pharmaceutical company. His work at Aventis has allowed him to focus on groundbreaking research and development in gene therapy. His expertise in this area has positioned him as a key figure in the advancement of medical treatments.
Collaborations
Some of his notable coworkers include Didier Branellec and Patrice Denefle. Their collaboration has contributed to the success of various projects within the company.
Conclusion
Jean-François Dedieu's contributions to gene therapy highlight the importance of innovation in medical science. His work continues to inspire advancements in treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile